Psychedelics: Science sabotaged by Social Media.

Area of Science:

• Psychopharmacology
• Neuroscience
• Mental Health Treatment

Background:

• High and low dose psychedelic drug development faces significant regulatory hurdles.
• Misinformation regarding psychedelic efficacy and safety persists among the public and professionals.

Purpose of the Study:

• To explore the potential of psychedelic microdosing as a viable alternative to high-dose psychedelic therapy.
• To assess the feasibility of microdosing for regulatory approval and integration into standard mental health treatment models.

Main Methods:

• Review of existing scientific literature on psychedelic drug development challenges.
• Analysis of regulatory pathways for psychotherapeutic agents versus high-dose psychedelic treatments.
• Discussion of potential therapeutic roles for both microdose and high-dose psychedelic agents.

Main Results:

• Psychedelic microdosing may circumvent many scientific and regulatory challenges associated with high-dose psychedelics.
• A microdosing model could align with standard outpatient treatment, offering cost-effectiveness and broader accessibility.
• Microdosing may avoid the stringent Risk Evaluation and Mitigation Strategies required for high-dose psychedelic therapies.

Conclusions:

• Psychedelic microdosing presents a promising avenue for developing new mental health treatments.
• Further research into the efficacy and long-term safety of microdosing is warranted.
• Microdosing could significantly expand treatment options for individuals with mental disorders.